Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
The past decades witnessed a significant stride in deciphering the pathophysiology of inflammatory bowel disease, which further advanced drug development adding several new biologicals and small molecules to the arsenal of available therapies. Surprisingly, this wealth in therapeutic options did not...
Saved in:
Main Authors: | Dahham Alsoud (Author), Séverine Vermeire (Author), Bram Verstockt (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
by: Wellens J, et al.
Published: (2023) -
Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2021) -
Probiotics as a promising treatment for inflammatory bowel disease
by: Mikov Momir M., et al.
Published: (2014) -
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
by: Gilles Duvoisin, et al.
Published: (2017) -
Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases
by: Wannee Kantasiripitak, et al.
Published: (2022)